” Whilst the Ricaurte Tale was unfolding, MAPS last but not least acquired FDA signal-off over a protocol for human trials of copyright for a procedure for PTSD, but only after it acquired a $one million insurance policy policy to indemnify the overview board.We gebruiken cookies om ervoor te zorgen dat onze Web-site zo soepel mogelijk draait. Al